文献速递临床试验与 GCP基础与转化研究

全脑放疗对比立体定向放射外科治疗小细胞肺癌1-10个脑转移的随机对照试验方案

Whole brain radiation therapy alone versus radiosurgery for patients with 1-10 brain metastases from small cell lung cancer (ENCEPHALON Trial): study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2018-07-16

BACKGROUND: Conventional whole brain radiotherapy (WBRT) has been established as the treatment standard in patients with cerebral metastases from small-cell lung cancer (SCLC), however, it has only modest efficacy and limited prospective data is available for WBRT as well as loca…

要点

  • SRS可能成为小细胞肺癌脑转移的有前景治疗选择
  • 主要终点为3个月时HVLT-R总回忆显著下降的神经认知功能

核心结论

  • 近期证据提示SRS可能对小细胞肺癌脑转移患者是有前景的治疗选择,本试验首次前瞻性研究WBRT与SRS的治疗反应、毒性和神经认知。

关键数值与推荐

  • 主要终点为3个月时霍普金斯词语学习测验修订版(HVLT-R)总回忆显著下降所客观测量的神经认知功能。
  • 次要终点包括颅内进展(局部肿瘤进展和新发脑转移数量)、颅外进展、总生存、脑转移死亡、局部(神经)无进展生存、无进展生存、其他认知表现变化、生活质量和毒性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Conventional whole brain radiotherapy (WBRT) has been established as the treatment standard in patients with cerebral metastases from small-cell lung cancer (SCLC), however, it has only modest efficacy and limited prospective data is available for WBRT as well as local treatments such as stereotactic radiosurgery (SRS). METHODS/DESIGN: The present single-center prospective randomized study, conducted at Heidelberg University Hospital, compares neurocognitive function, as objectively measured by significant deterioration in Hopkins Verbal Learning Test - Revised total recall at 3 months. Fifty-six patients will be randomized to receive either SRS of all brain metastases (up to ten lesions) or WBRT. Secondary endpoints include intracranial progression (local tumor progression and number of new cerebral metastases), extracranial progression, overall survival, death due to brain metastases, local (neurological) progression-free survival, progression-free survival, changes in other cognitive performance measures, quality of life and toxicity. DISCUSSION: Recent evidence suggests that SRS might be a promising treatment option for SCLC patients with brain metastases. The present trial is the first to prospectively investigate the treatment response, toxicity and neurocognition of WBRT and SRS in SCLC patients. TRIAL REGISTRATION: Clinicaltrials.gov NCT03297788 . Registered September 29, 2017.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Bernhardt D, Hommertgen A, Schmitt D, et al. Whole brain radiation therapy alone versus radiosurgery for patients with 1-10 brain metastases from small cell lung cancer (ENCEPHALON Trial): study protocol for a randomized controlled trial. Trials. 2018. PMID: 30012190. doi:10.1186/s13063-018-2745-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。